Novak M - Search Results

1

Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.

Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, Rolkova G, Kontsekova E, Novak M. Zilka N, et al. Among authors: novak m. FEBS Lett. 2006 Jun 26;580(15):3582-8. doi: 10.1016/j.febslet.2006.05.029. Epub 2006 May 22. FEBS Lett. 2006. PMID: 16753151 Free article.

2

Quick purification of recombinant human truncated tau proteins for immunoanalysis.

Kontsekova E, Cattaneo A, Novak M. Kontsekova E, et al. Among authors: novak m. J Immunol Methods. 1995 Sep 25;185(2):245-8. doi: 10.1016/0022-1759(95)00120-y. J Immunol Methods. 1995. PMID: 7561135

3

Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody.

Cattaneo A, Capsoni S, Margotti E, Righi M, Kontsekova E, Pavlik P, Filipcik P, Novak M. Cattaneo A, et al. Among authors: novak m. J Neurosci. 1999 Nov 15;19(22):9687-97. doi: 10.1523/JNEUROSCI.19-22-09687.1999. J Neurosci. 1999. PMID: 10559378 Free PMC article.

4

Mapping the C terminal epitope of the Alzheimer's disease specific antibody MN423.

Khuebachova M, Verzillo V, Skrabana R, Ovecka M, Vaccaro P, Panni S, Bradbury A, Novak M. Khuebachova M, et al. Among authors: novak m. J Immunol Methods. 2002 Apr 1;262(1-2):205-15. doi: 10.1016/s0022-1759(02)00006-6. J Immunol Methods. 2002. PMID: 11983234

5

A rapid immunohistochemical primary screening assay for hybridomas.

Zilka N, Vechterová L, Kontseková E, Novák M. Zilka N, et al. Among authors: novak m. J Immunol Methods. 2003 Jan 15;272(1-2):49-53. doi: 10.1016/s0022-1759(02)00371-x. J Immunol Methods. 2003. PMID: 12505711

6

DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope.

Vechterova L, Kontsekova E, Zilka N, Ferencik M, Ravid R, Novak M. Vechterova L, et al. Among authors: novak m. Neuroreport. 2003 Jan 20;14(1):87-91. doi: 10.1097/00001756-200301200-00017. Neuroreport. 2003. PMID: 12544837

7

Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases.

Csokova N, Skrabana R, Liebig HD, Mederlyova A, Kontsek P, Novak M. Csokova N, et al. Among authors: novak m. Protein Expr Purif. 2004 Jun;35(2):366-72. doi: 10.1016/j.pep.2004.01.012. Protein Expr Purif. 2004. PMID: 15135415

8

Folding of Alzheimer's core PHF subunit revealed by monoclonal antibody 423.

Skrabana R, Kontsek P, Mederlyova A, Iqbal K, Novak M. Skrabana R, et al. Among authors: novak m. FEBS Lett. 2004 Jun 18;568(1-3):178-82. doi: 10.1016/j.febslet.2004.04.098. FEBS Lett. 2004. PMID: 15196943 Free article.

9

First insert of tau protein is present in all stages of tau pathology in Alzheimer's disease.

Soltys K, Rolkova G, Vechterova L, Filipcik P, Zilka N, Kontsekova E, Novak M. Soltys K, et al. Among authors: novak m. Neuroreport. 2005 Oct 17;16(15):1677-81. doi: 10.1097/01.wnr.0000181582.95764.79. Neuroreport. 2005. PMID: 16189476

10

Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis.

Skrabana R, Sevcik J, Novak M. Skrabana R, et al. Among authors: novak m. Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1085-97. doi: 10.1007/s10571-006-9083-3. Epub 2006 Jun 16. Cell Mol Neurobiol. 2006. PMID: 16779670 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,891 results

Search Page

Filters